Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.
Year: 2012
Type: article
Study design: Observational Study
Source: Blood
Authors: Girindra G Raval, Morie A Gertz, Martha Q Lacy, Suzanne R Hayman, Shaji K. Kumar, Francis K Buadi, John A. Lust, Steven Zeldenrust, David Dingli, Robert L Hall, Lisa Hwa, Yi Lin, Prashant Kapoor, Thomas E. Witzig, Robert A. Kyle, Stephen Russell, Nelson Leung, S. Vincent Rajkumar, Angela Dispenzieri
Institution: Mayo Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2559818901